Morgan Stanley analyst Mark Purcell raised the firm’s price target on AstraZeneca to 12,700 GBp from 12,600 GBp and keeps an Overweight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AZN:
- 5 Healthcare Stocks to Buy Now, According to Analysts – August 2023
- Sanofi says CDC panel unanimously recommends use of Beyfortus for infants
- AstraZeneca and Sanofi RSV drug wins support of CDC panel, Bloomberg says
- Zentalis appoints Freeman as Chief Strategy Officer
- AstraZeneca (AZN) Announces Q3 Dividend: Read On for Important Dates